Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)
<p>Canine hypoadrenocorticism likely arises from immune-mediated destruction of adrenocortical tissue, leading to glucocorticoid and mineralocorticoid deficiency. In humans with autoimmune Addison’s disease (AAD) or autoimmune polyendocrine syndrome (APS), circulating autoantibodies have been...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Public Library of Science
2015
|
| _version_ | 1826257364759609344 |
|---|---|
| author | Boag, A Christie, M McLaughlin, K Syme, H Graham, P Catchpole, B |
| author_facet | Boag, A Christie, M McLaughlin, K Syme, H Graham, P Catchpole, B |
| author_sort | Boag, A |
| collection | OXFORD |
| description | <p>Canine hypoadrenocorticism likely arises from immune-mediated destruction of adrenocortical tissue, leading to glucocorticoid and mineralocorticoid deficiency. In humans with autoimmune Addison’s disease (AAD) or autoimmune polyendocrine syndrome (APS), circulating autoantibodies have been demonstrated against enzymes associated with adrenal steroid synthesis. The current study investigates autoantibodies against steroid synthesis enzymes in dogs with spontaneous hypoadrenocorticism. Coding regions of canine <i>CYP21A2</i> (21-hydroxylase; 21-OH), <i>CYP17A1</i> (17-hydroxylase; 17-OH), <i>CYP11A1</i> (P450 side-chain cleavage enzyme; P450scc) and <i>HSD3B2</i> (3β hydroxysteroid dehydrogenase; 3βHSD) were amplified, cloned and expressed as <sup>35</sup>S-methionine radiolabelled recombinant protein. In a pilot study, serum samples from 20 dogs with hypoadrenocorticism and four unaffected control dogs were screened by radio-immunoprecipitation assay. There was no evidence of reactivity against 21-OH, 17-OH or 3βHSD, but five dogs with hypoadrenocorticism showed immunoreactivity to P450scc compared with controls. Serum samples were subsequently obtained from 213 dogs diagnosed with hypoadrenocorticism and 110 dogs from a hospital control population. Thirty control dogs were randomly selected to establish a threshold for antibody positivity (mean + 3 × standard deviation). Dogs with hypoadrenocorticism were more likely to be P450scc autoantibody positive than hospital controls (24% vs. 1.2%, respectively; <i>p</i> = 0.0016). Sex was significantly associated with the presence of P450scc autoantibodies in the case population, with 30% of females testing positive compared with 17% of males (<i>p</i> = 0.037). Significant associations with breed (<i>p</i> = 0.015) and DLA-type (DQA1*006:01 allele; <i>p</i> = 0.017) were also found. This cross-sectional study indicates that P450scc autoantibodies are present in a proportion of dogs affected with hypoadrenocorticism.</p> |
| first_indexed | 2024-03-06T18:17:02Z |
| format | Journal article |
| id | oxford-uuid:04f5e25c-a47c-45d6-a930-29e64868457a |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:17:02Z |
| publishDate | 2015 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:04f5e25c-a47c-45d6-a930-29e64868457a2022-03-26T08:54:35ZAutoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:04f5e25c-a47c-45d6-a930-29e64868457aSymplectic Elements at OxfordPublic Library of Science2015Boag, AChristie, MMcLaughlin, KSyme, HGraham, PCatchpole, B <p>Canine hypoadrenocorticism likely arises from immune-mediated destruction of adrenocortical tissue, leading to glucocorticoid and mineralocorticoid deficiency. In humans with autoimmune Addison’s disease (AAD) or autoimmune polyendocrine syndrome (APS), circulating autoantibodies have been demonstrated against enzymes associated with adrenal steroid synthesis. The current study investigates autoantibodies against steroid synthesis enzymes in dogs with spontaneous hypoadrenocorticism. Coding regions of canine <i>CYP21A2</i> (21-hydroxylase; 21-OH), <i>CYP17A1</i> (17-hydroxylase; 17-OH), <i>CYP11A1</i> (P450 side-chain cleavage enzyme; P450scc) and <i>HSD3B2</i> (3β hydroxysteroid dehydrogenase; 3βHSD) were amplified, cloned and expressed as <sup>35</sup>S-methionine radiolabelled recombinant protein. In a pilot study, serum samples from 20 dogs with hypoadrenocorticism and four unaffected control dogs were screened by radio-immunoprecipitation assay. There was no evidence of reactivity against 21-OH, 17-OH or 3βHSD, but five dogs with hypoadrenocorticism showed immunoreactivity to P450scc compared with controls. Serum samples were subsequently obtained from 213 dogs diagnosed with hypoadrenocorticism and 110 dogs from a hospital control population. Thirty control dogs were randomly selected to establish a threshold for antibody positivity (mean + 3 × standard deviation). Dogs with hypoadrenocorticism were more likely to be P450scc autoantibody positive than hospital controls (24% vs. 1.2%, respectively; <i>p</i> = 0.0016). Sex was significantly associated with the presence of P450scc autoantibodies in the case population, with 30% of females testing positive compared with 17% of males (<i>p</i> = 0.037). Significant associations with breed (<i>p</i> = 0.015) and DLA-type (DQA1*006:01 allele; <i>p</i> = 0.017) were also found. This cross-sectional study indicates that P450scc autoantibodies are present in a proportion of dogs affected with hypoadrenocorticism.</p> |
| spellingShingle | Boag, A Christie, M McLaughlin, K Syme, H Graham, P Catchpole, B Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease) |
| title | Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease) |
| title_full | Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease) |
| title_fullStr | Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease) |
| title_full_unstemmed | Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease) |
| title_short | Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease) |
| title_sort | autoantibodies against cytochrome p450 side chain cleavage enzyme in dogs canis lupus familiaris affected with hypoadrenocorticism addison s disease |
| work_keys_str_mv | AT boaga autoantibodiesagainstcytochromep450sidechaincleavageenzymeindogscanislupusfamiliarisaffectedwithhypoadrenocorticismaddisonsdisease AT christiem autoantibodiesagainstcytochromep450sidechaincleavageenzymeindogscanislupusfamiliarisaffectedwithhypoadrenocorticismaddisonsdisease AT mclaughlink autoantibodiesagainstcytochromep450sidechaincleavageenzymeindogscanislupusfamiliarisaffectedwithhypoadrenocorticismaddisonsdisease AT symeh autoantibodiesagainstcytochromep450sidechaincleavageenzymeindogscanislupusfamiliarisaffectedwithhypoadrenocorticismaddisonsdisease AT grahamp autoantibodiesagainstcytochromep450sidechaincleavageenzymeindogscanislupusfamiliarisaffectedwithhypoadrenocorticismaddisonsdisease AT catchpoleb autoantibodiesagainstcytochromep450sidechaincleavageenzymeindogscanislupusfamiliarisaffectedwithhypoadrenocorticismaddisonsdisease |